Have you been diagnosed with Ulcerative Colitis (UC)? You may be eligible to participate in the IM011-024 clinical study.

About the IM011-024 Study

The IM011-024 study is for people diagnosed with moderate to severe UC. The purpose of this study is to test the safety and efficacy (how well it works) of the study drug BMS-986165 compared to placebo. A placebo is an inactive substance that looks like the study drug but has no medical effect. The study drug MBS-986165 and the placebo will be taken by mouth in this study. This is a double-blind study, which means neither you nor the study doctor will know which study treatment you are receiving.

All study-related medical procedures and tests will be provided at no cost to you.

Eligibility

Eligible study participates must:

• Be between 18 and 75 years of age
• Be diagnosed with moderate to severe UC
• Have tried 1 or more standard of care treatments that did not work, stopped working, or were not tolerated.

The study doctor will also check other eligibility requirements.